Latest News

Alzheimer's prevention trial to monitor reactions to higher disease risk status

A new clinical trial will soon begin testing whether early medical intervention in people at risk for Alzheimer's can slow down progression of disease pathology before symptoms emerge. As part of the overall prevention trial, neurodegenerative ethics experts will monitor how learning about their risk of developing Alzheimer's impacts trial participants.
View full story

Post your comment.


  • New protein biomarker identifies damaged brain wiring after concussion

  • Fruit flies provide new insight into body's rhythms

  • High-fat diet prompts immune cells to start eating connections between neurons

  • Want to remember new names? Sleep on it

  • Adults aged 50-59 now largest age group in opioid treatment programs

  • Children who take ADHD medicines have trouble sleeping, new study shows

  • Blood from small children 'remembers' prenatal smoking exposure

  • Oxytocin increases social altruism

  • First-of-kind dopamine measurements in human brain reveal insights into how we learn

  • Young women who survive cardiovascular event have long-term risks